Study the antipyretic effect of Kiratadi Syrup in school going childre
Phase 2
- Conditions
- Health Condition 1: B349- Viral infection, unspecified
- Registration Number
- CTRI/2023/01/048744
- Lead Sponsor
- Dr.Shivpratap Biradar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Children between the age of 6-12 years irrespective of gender and socioeconomic status.
2)Children with signs and symptoms of jwara (fever).
3)Children with fever between 37.4(99.3â?°f)to 38.3â?°c(100.94â?°f)
4)children suffering from fever for less than 48hr.
5)Children whose parents are ready to participate in the clinical trial by giving informed written assent.
Exclusion Criteria
1)Children with fever >38.3â?°C(100.94â?°F)
2)Children suffer from Fever for more than 48hr.
3)Children suffering from the common cold, and cough. Vomiting diarrhea fever with rash and the common conditions
4)K/C/O Systemic illness.
5)Patients with history of Febrile Convulsions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Axillary temperature of the patientsTimepoint: 5 days study with 0,3rd and 5th day
- Secondary Outcome Measures
Name Time Method To observe the adverse effect of Kiratadi SyrupTimepoint: 5 days study with 0,3rd and 5th day